| Â | PFS | OS |
|---|
| Â | HR (95%CI) | P value | HR (95%CI) | P value |
|---|
TTS
a
| Â | Â | Â | Â |
≤ 20 | 1 (Reference) |  | 1 (Reference) |  |
21–25 | 1.15 (0.89–1.48) | 0.283 | 1.27 (0.91–1.77) | 0.169 |
26–29 | 1.24 (0.95–1.62) | 0.115 | 1.56 (1.09–2.21) | 0.014 |
> 29 | 1.24 (0.94–1.62) | 0.125 | 1.49 (1.05–2.12) | 0.027 |
TTS
b
| 1.003 (0.997–1.010) | 0.288 | 1.010 (1.002–1.018) | 0.018 |
PÂ
for trend
c
| Â | 0.103* | Â | 0.016* |
- Abbreviation: PFS, Progression-free survival; OS, Overall survival; TTS, Time to interval debulking surgery after the completion of neoadjuvant chemotherapy; HR, Hazard ratio; CI, Confidence interval; *, P value for Ptrend
- a Adjusted for age, type, grade, stage, residual disease, cycle of neoadjuvant chemotherapy and TTS (included as a quartile categorical variable)
- b Adjusted for age, type, grade, stage, residual disease, cycle of neoadjuvant chemotherapy and TTS (included as a continuous variable)
- c Adjusted for age, type, grade, stage, residual disease and cycle of neoadjuvant chemotherapy
